H
H. Sörensen
Researcher at Praxis
Publications - 6
Citations - 1003
H. Sörensen is an academic researcher from Praxis. The author has contributed to research in topics: Rheumatology & Ankylosing spondylitis. The author has an hindex of 5, co-authored 6 publications receiving 924 citations.
Papers
More filters
Journal ArticleDOI
Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project.
Marina Backhaus,Sarah Ohrndorf,Herbert Kellner,J. Strunk,T. M. Backhaus,Wolfgang Hartung,H. Sattler,Katinka Albrecht,J. Kaufmann,Karsten Becker,H. Sörensen,L. Meier,G.-R. Burmester,Wolfgang A. Schmidt +13 more
TL;DR: The German US7 score is a viable tool for examining patients with arthritis in daily rheumatologic practice because it significantly reflects therapeutic response.
Journal ArticleDOI
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab.
Xenofon Baraliakos,Joachim Listing,J Brandt,Angela Zink,Rieke Alten,Gerd R Burmester,E Gromnica-Ihle,Herbert Kellner,Matthias Schneider,H. Sörensen,Henning Zeidler,Martin Rudwaleit,Joachim Sieper,Juergen Braun +13 more
TL;DR: Discontinuation of long-term therapy with infliximab eventually led to relapse of disease activity in all patients but one and patients who were in partial remission according to the ASAS criteria and those with normal C-reactive protein levels at the time point of withdrawal had longer times to relapse after discontinuation of the treatment.
Journal ArticleDOI
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
Hans-Peter Tony,Gerd R Burmester,Hendrik Schulze-Koops,Mathias Grunke,Joerg Henes,Ina Kötter,Judith Haas,L. Unger,Svjetlana Lovric,Marion Haubitz,Rebecca Fischer-Betz,Gamal Chehab,Andrea Rubbert-Roth,Christof Specker,Jutta Weinerth,Julia Holle,Ulf Müller-Ladner,Ramona König,Christoph Fiehn,Philip Burgwinkel,Klemens Budde,H. Sörensen,Michael Meurer,Martin Aringer,Bernd C. Kieseier,Cornelia Erfurt-Berge,Michael Sticherling,Roland Veelken,Ulf Ziemann,Frank Strutz,Praxis von Wussow,Florian Meier,Nico Hunzelmann,Enno Schmidt,Raoul Bergner,Andreas Schwarting,Rüdiger Eming,Michael Hertl,Rudolf Stadler,Michael Schwarz-Eywill,Siegfried Wassenberg,Martin Fleck,Claudia Metzler,Uwe K. Zettl,Jens Westphal,Stefan Heitmann,Anna Laura Herzog,Heinz Wiendl,Waltraud Jakob,Elvira Schmidt,Klaus Freivogel,Thomas Dörner +51 more
TL;DR: Data from this registry indicate that rituximab is a commonly employed, well-tolerated therapy with potential beneficial effects in standard of care-refractory autoimmune diseases, and support the results from other open-label, uncontrolled studies.
Journal ArticleDOI
Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.
Xenofon Baraliakos,J Brandt,Joachim Listing,Hildrun Haibel,H. Sörensen,Martin Rudwaleit,J. Sieper,J. Braun +7 more
TL;DR: The clinical efficacy and safety of etanercept in patients with active ankylosing spondylitis without simultaneous administration of DMARDs or steroids over 2 years of continuous treatment is confirmed.
Journal ArticleDOI
Clinical response to withdrawal of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab (vol 7, pg R439, 2005)
Xenofon Baraliakos,Joachim Listing,J Brandt,Angela Zink,Rieke Alten,G.-R. Burmester,E Gromnica-Ihle,Herbert Kellner,Matthias Schneider,H. Sörensen,Henning Zeidler,Martin Rudwaleit,J. Sieper,Jürgen Braun +13 more
TL;DR: This data indicates that the prophylactic use of EMT in the management of central giant cell granuloma is a profitable alternative for regenerative medicine and may have implications for wound healing.